Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma.
about
Transforming growth factor β as regulator of cancer stemness and metastasisPeroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway.MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.miR-21 is involved in transforming growth factor β1-induced chemoresistance and invasion by targeting PTEN in breast cancer.Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL.Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance.
P2860
Q28077319-98AF540B-CAFC-415D-BC12-79FA6F25B702Q37227987-40522098-F867-435F-9B92-C36E56CDCD99Q37295326-15C2ED4E-8C32-40D2-981A-88FCDF941B92Q37513938-AEEE954E-551F-46B9-A9A8-A710C12EC034Q38703092-6BEFFA77-B670-49DC-9795-9B27B105D1CBQ41061766-43D469E0-8B8A-40E6-999C-0EAAB4E3061DQ47140406-4489D819-DECE-44E7-B54D-BD5589740815Q47233500-8A461079-EF0E-46B3-AC5F-9E9206235695Q52714580-58A96A88-B08C-497B-84D8-28D2DED2FFC8
P2860
Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Axl as a downstream effector o ...... esistance in breast carcinoma.
@en
type
label
Axl as a downstream effector o ...... esistance in breast carcinoma.
@en
prefLabel
Axl as a downstream effector o ...... esistance in breast carcinoma.
@en
P2093
P2860
P1433
P1476
Axl as a downstream effector o ...... esistance in breast carcinoma.
@en
P2093
Dongliang Ren
Yanxin Gong
Yongfu Zhao
P2860
P2888
P304
P356
10.1007/S13277-014-2677-3
P577
2014-10-21T00:00:00Z
P6179
1004096269